---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-032627"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-18T23:33:14.518133+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# X4 Pharmaceuticals secures $40M equity line with Lincoln Park Capital

## Summary
- Company may sell up to $40M of common stock to Lincoln Park over 24 months.
- Purchase price set at 97% of the lower of lowest or 3-day-average closing price.
- Regular purchases capped at 30k–60k shares per day based on stock price thresholds.
- Issued 137,099 commitment shares to Lincoln Park as a fee for entering the agreement.

## SEC filing metadata
- accession: 0001628280-25-032627
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828025032627/0001628280-25-032627-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828025032627/xfor-20250623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-032627
- JSON: https://secwatch.observer/filing/0001628280-25-032627.json
- Plain text: https://secwatch.observer/filing/0001628280-25-032627.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.